Follow The Filings

XYL Xylem

Xylem earnings company data as of 1:58 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 1.47 — —
Rev — — —

Insider trades

Open-market buys and sales by XYL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All XYL insider trades
  • $141K bought by 1 insider
  • $2.3M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Geri-Michelle McShane SVP, CAO
    Sale
    $501K 4,269 shares at $117.46 54% of stake
    Traded May 7 Filed May 8
    ↗
  2. Jerome A Peribere Director
    Buy
    $141K 1,210 shares at $116.61 +4.7% to stake
    Traded May 4 Filed May 4
    ↗
  3. Victoria D Harker Director
    Sale
    $252K 1,700 shares at $148.14 9.2% of stake
    Traded Nov 4, 2025 Filed Nov 5, 2025
    ↗
  4. Claudia S Toussaint EVP, Cpso
    Sale
    $1.6M 10,421 shares at $152.64 25% of stake
    Traded Oct 30, 2025 Filed Oct 31, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 49 stock grants, 34 share withholdings for taxes, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 1.01,1.02,2.03,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.